India Rejects Novartis' Cancer Drug Patent - Presented by: The Aol. On Network

India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent a new version of a cancer drug in a landmark decision that healthcare activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
FB $ 68.94 0.46 ▼ 0.66%
BAC $ 15.525 0.01 ▲ 0.03%
RF $ 10.155 0.04 ▼ 0.34%
AAPL $ 94.255 0.32 ▲ 0.34%
AMD $ 3.84 0.06 ▲ 1.59%
INTC $ 34.59 0.53 ▲ 1.56%
PBR $ 17.375 0.05 ▼ 0.26%
GE $ 25.885 0.10 ▼ 0.37%

As of 7/22/2014, 09:55 AM
More Most Active